Status:
COMPLETED
Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease
Lead Sponsor:
AstraZeneca
Conditions:
Myocardial Ischaemia
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether treatment with 40mg of Rosuvastatin for 8 weeks will reduce the number of episodes of myocardial ischaemia suffered in subjects with coronary artery d...
Eligibility Criteria
Inclusion
- Evidence of Coronary arterial disease
- Suffering ischaemic episodes/exercise induced ischaemia
- Not taking any cholesterol lowering medication
Exclusion
- Unstable angina or heart attack less than one month before trial entry
- Coronary arterial surgery as defined by protocol
- Uncontrolled hypertension, diabetes, hypothyroidism or laboratory values as defined by the protocol.
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2002
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT00657527
Start Date
December 1 2001
End Date
December 1 2002
Last Update
March 16 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.